Inhaled Nitric Oxide Market | CAGR of 6.8% (2026-2032)
The global Inhaled Nitric Oxide Market size reached 1,239.3 USD Million in 2025. Looking forward, MarketsGlob expects the market to reach 1,964.15 USD Million by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2026-2032.
Inhaled nitric oxide (iNO) is a medical gas used as a vasodilator to improve oxygenation in patients with respiratory conditions. It is commonly used in neonatal care and for treating conditions such as acute respiratory distress syndrome (ARDS), asthma, COPD, and other critical illnesses.
Key Market Drivers
- Rising prevalence of respiratory diseases worldwide
- Increasing demand for advanced neonatal care
- Growing adoption of gas-based therapies in hospitals
- Expansion of healthcare infrastructure and critical care facilities
Market Outlook
With increasing focus on respiratory care and critical treatment solutions, inhaled nitric oxide is expected to see steady growth in the healthcare sector.
Inhaled Nitric Oxide Market
Market forecast to grow at a CAGR of 6.8%
Note:The image is for illustrative purposes only
Key Players in the Market
The report includes a detailed analysis of both established and emerging companies in the market. Key players are highlighted based on their product offerings and other relevant factors, with consideration given to their year of market entry.
Major players includes
- Air Liquide Healthcare
- BOC Healthcare
- Matheson Tri-Gas Inc.
- Merck KGaA
- Mallinckrodt Pharmaceuticals (Novoteris)
- Nu-Med Plus Inc.
- Perma Pure LLC
- Praxair Distribution Inc.
- HALMA PLC
- LINDE PLC
- Bellerophan Therapeutics Inc.
(Please note that the list of players mentioned here is not final. We encourage you to request a sample report to review the most up-to-date list of all relevant players.)
Segmentation for Inhaled Nitric Oxide Market
Products Segment Analysis
- Gas
- Delivery Systems
Applications Segment Analysis
- Neonatal Respiratory Treatment
- Asthma and COPD
- Acute Respiratory Distress Syndrome
- Malaria Treatment
- Tuberculosis Treatment
- Other Applications
(Please note that the segmentation provided in this report is not limited to these categories. We can further break down the data into additional segments as per your specific requirements. We encourage you to request a sample report to explore the detailed scope of our research and customized insights.)
Sales Channel Segment Analysis
- Direct Channel
- Distribution Channel
Market segment by Region/Country including:
- North America (United States, Canada, Mexico)
- Europe (Germany, United Kingdom, France, Italy, Russia, Spain, Benelux, Poland, Austria, Portugal, Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, Australia, Taiwan, Rest of Asia Pacific)
- South America (Brazil, Argentina, Colombia, Chile, Peru, Venezuela, Rest of South America)
- Middle East & Africa (UAE, Saudi Arabia, South Africa, Egypt, Nigeria, Rest of Middle East & Africa)
Report Coverage:
| Base Year of the Analysis | 2025 |
|---|---|
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2032 |
| Types Covered | Gas, Delivery Systems |
| Applications Covered | Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, Other Applications |
| Companies Covered |
Air Liquide Healthcare, BOC Healthcare, Matheson Tri-Gas Inc., Merck KGaA, Mallinckrodt Pharmaceuticals (Novoteris), Nu-Med Plus Inc., Perma Pure LLC, Praxair Distribution Inc., HALMA PLC, LINDE PLC, Bellerophan Therapeutics Inc. (Please note that the list of players mentioned here is not final. We encourage you to request a sample report to review the most up-to-date list of all relevant players.) |
| Sales Channels Covered | Direct Channel, Distribution Channel |
| Regions Covered | North America, Europe, Asia-Pacific, South America, Middle East and Africa |
| Countries Covered | United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Russia, Spain, Benelux, Poland, Austria, Portugal, Rest of Europe, China, Japan, Korea, India, Southeast Asia, Australia, Taiwan, Rest of Asia Pacific, Brazil, Argentina, Colombia, Chile, Peru, Venezuela, Rest of South America, UAE, Saudi Arabia, South Africa, Egypt, Nigeria, Rest of Middle East & Africa |
| Customization Scope | We offer extensive customization options for different segments at the region/country-level, ensuring that specific needs are met. Furthermore, our services extend to additional customization based on your unique requirements. |
| Purchase Options | We have three plans to opt for: Standard Plan (PDF), Advanced Plan (PDF + Excel Data Pack) & Extended Plan (PDF + Excel Data Pack + Periodic Update). For more details, please check details of plan types & features. |
Frequently Asked Questions
Clientele
